Chemoradiotherapy in patients with anal cancer: Impact of length of unplanned treatment interruption on outcome

References

• Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000; 342: 792–800
   PubMed Web of Science ®Google Scholar
• Bartelink H, Roelofson F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997; 15: 2040–9
   PubMed Web of Science ®Google Scholar
• UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996;348:1049–54.
   PubMed Web of Science ®Google Scholar
• Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, et al. Role of Mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 1996; 14: 2527–39
   PubMed Web of Science ®Google Scholar
• Cummings BJ, Brierley JD. Anal canal. Principles and practice of radiation oncology4th ed., CA Perez, LW Brady, EC Halperin, RK Schmidt-Ullrich. Lippincott Williams & Wilkins, Philadelphia 2004; 1630–48
   Google Scholar
• Graf R, Wust P, Hildebrandt B, Gogler H, Ullrich R, Herrmann R, et al. Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy. Oncology 2003; 65: 14–22
   PubMed Web of Science ®Google Scholar
• Deniaud-Alexandre E, Touboul E, Tiret E. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 2003; 56: 1259–73
   PubMed Web of Science ®Google Scholar
• Nigro ND, Vaitkevicius VK, Considine B, Jr. Combined therapy for cancer of the anal canal: A preliminary report. Dis Colon Rectum 1974; 17: 354–6
   PubMed Web of Science ®Google Scholar
• Cummings BJ, Keane TJ, O'Sullivan B, Wong CS, Catton CN. Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-Fluorouracil with and without Mitomycin C. Int J Radiat Oncol Biol Phys 1991; 21: 1115–25
   PubMed Web of Science ®Google Scholar
• Esiashvili N, Landry J, Matthews RH. Carcinoma of the anus: Strategies in management. Oncologist 2002; 7: 188–99
   PubMed Web of Science ®Google Scholar
• Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992; 23: 457–67
   PubMed Web of Science ®Google Scholar
• Girinsky T, Rey A, Roche B, Haie C, Gerbaulet A, Randrianarivello H, et al. Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 1993; 27: 1051–6
   PubMed Web of Science ®Google Scholar
• Vuong T, Devic S, Belliveau P, Muanza T, Hegyi G. Contribution of conformal therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiotherapy: Results of a phase II study. Int J Radiat Oncol Biol Phys 2003; 56: 823–31
   PubMed Web of Science ®Google Scholar
• Dorr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol 2001; 61: 223–31
   PubMed Web of Science ®Google Scholar
• Peiffert D, Bey P, Pernot M, Guillemin F, Luporsi E, Hoffstetter S, et al. Conservative treatment by irradiation of epidermoid cancers of the anal canal: Prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys 1997; 37: 313–24
   PubMed Web of Science ®Google Scholar
• Weber DC, Kurtz J, Allal AS. The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 2001; 50: 675–80
   PubMed Web of Science ®Google Scholar
• Ceresoli GL, Ferreri AJ, Cordio S, Villa E. Role of dose intensity in conservative treatment of anal canal carcinoma. Report of 35 cases. Oncology 1998; 55: 525–32
   PubMed Web of Science ®Google Scholar
• Allal AS, Mermillod B, Roth AD, Marti MC, Kurtz JM. The impact of treatment factors of local control in T2–T3 anal carcinomas treated by radiotherapy with or without chemotherapy. Cancer 1997; 79: 2329–35
   PubMed Web of Science ®Google Scholar
• Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS, DeLaney TF. Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 1997; 39: 651–7
   PubMed Web of Science ®Google Scholar
• Bosset JF, Roelofsen F, Morgan DA, Budach V, Coucke P, Jager JJ, et al. Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups. Eur J Cancer 2003; 39: 45–51
   PubMed Web of Science ®Google Scholar
• Gerard JP, Ayzac L, Hun D, Romestaing P, Coquard R, Ardiet JM, et al. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Radiother Oncol 1998; 46: 249–56
   PubMed Web of Science ®Google Scholar
• Hung A, Crane C, Delclos M, Ballo M, Ajani J, Lin E, et al. Cisplatin-based combined modality therapy for anal carcinoma: A wider therapeutic index. Cancer 2003; 97: 1195–202
   PubMed Web of Science ®Google Scholar
• Peiffert D, Giovannini M, Ducreux M, Michel P, Francois E, Lemanski C, et al. Digestive Tumours Group of the French ‘Federation Nationale des Centres de Lutte Contre le Cancer’. High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study. Ann Oncol 2001; 12: 397–404
   PubMed Web of Science ®Google Scholar